Invesco QQQ stock is falling shaking out all dip buyers

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Invesco QQQ trust (QQQ) is currently trading at $264, down more than 3 percent today. Perhaps a few too many people bought the dip yesterday thinking there’d be a Santa Rally. The market is shaking out all dip buyers and putting them in a world of hurt this morning.

QQQ Stock Chart

The QQQ’s have broken through $270 and $267 support. $267 is still an important pivot level to watch today. 

Above it the next targets are $270, $272 and there is a gap to fill to yesterday’s close at $273.45

Below $267,there is a gap to fill at $263.32 and then $261/$259 is a major prior support area.

The market loves to do the meanest thing possible and we’re seeing that in the QQQ’s this morning.